Affymetrix Inc (AFFX)

14.01
0.02 0.14
NASDAQ : Technology
Prev Close 13.99
Open 14.03
Day Low/High 14.00 / 14.05
52 Wk Low/High 8.28 / 16.15
Volume 5.03M
Avg Volume 3.49M
Exchange NASDAQ
Shares Outstanding 80.54M
Market Cap 1.13B
EPS 0.13
P/E Ratio 107.61
Div & Yield N.A. (N.A)
Affymetrix Names GenoSplice As Its Preferred Data Analysis Service Provider Increasing Accessibility For Bioinformatics In Genomic Research

Affymetrix Names GenoSplice As Its Preferred Data Analysis Service Provider Increasing Accessibility For Bioinformatics In Genomic Research

Affymetrix, Inc. (NASDAQ:AFFX) announced a co-marketing agreement today naming GenoSplice, Inc.

Affymetrix And DNA Link Sign Partnership For Forensic Test Development For Human Identification

Affymetrix And DNA Link Sign Partnership For Forensic Test Development For Human Identification

Affymetrix, Inc. (NASDAQ: AFFX) and DNA Link, Inc.

Affymetrix To Webcast Presentation At The 2013 Leerink Swann Global Healthcare Conference

Affymetrix To Webcast Presentation At The 2013 Leerink Swann Global Healthcare Conference

Affymetrix, Inc. (Nasdaq:AFFX) today announced that it will webcast the Company’s presentation at the Leerink Swann Global Healthcare Conference in New York City on Thursday, February 14, 2013.

Affymetrix Inc. Stock Upgraded (AFFX)

Affymetrix Inc. Stock Upgraded (AFFX)

Affymetrix (Nasdaq:AFFX) has been upgraded by TheStreet Ratings from a sell to hold.

Affymetrix Reports Fourth Quarter And Fiscal Year 2012 Results

Affymetrix Reports Fourth Quarter And Fiscal Year 2012 Results

Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the three and twelve months ended December 31, 2012.

5 Under-$10 Stocks Primed to Rise in January

5 Under-$10 Stocks Primed to Rise in January

Traders savvy enough to follow the low-priced names and trade them with discipline and sound risk management are banking ridiculous coin on a regular basis.

Affymetrix Announces Preliminary Fourth Quarter Revenue Of $84 Million And Implements Corporate Restructuring To Accelerate Path To Profitability

Affymetrix Announces Preliminary Fourth Quarter Revenue Of $84 Million And Implements Corporate Restructuring To Accelerate Path To Profitability

Affymetrix, Inc., (NASDAQ: AFFX) today announced that based on preliminary financial data, the Company expects total revenue for the fourth quarter of 2012 will be approximately $84 million, including $18 million from...

Affymetrix To Webcast Presentation At The 31st Annual JP Morgan Healthcare Conference

Affymetrix To Webcast Presentation At The 31st Annual JP Morgan Healthcare Conference

Affymetrix, Inc. (Nasdaq:AFFX) today announced that it will webcast the Company’s presentation at the 31st Annual JP Morgan Healthcare Conference in San Francisco, California on Thursday, January 10, 2013.

Affymetrix Inc. Stock Downgraded (AFFX)

Affymetrix Inc. Stock Downgraded (AFFX)

Affymetrix (Nasdaq:AFFX) has been downgraded by TheStreet Ratings from from a hold to sell.

Affymetrix Announces Redemption Of 3.50% Senior Convertible Notes

Affymetrix Announces Redemption Of 3.50% Senior Convertible Notes

Affymetrix, Inc., (NASDAQ: AFFX) today has given notice of its intention to redeem all of the outstanding 3.

Affymetrix Announces Research Collaboration With Centre For Proteomic And Genomic Research (CPGR) In South Africa

Affymetrix Announces Research Collaboration With Centre For Proteomic And Genomic Research (CPGR) In South Africa

Affymetrix, Inc. (NASDAQ: AFFX) today announced a research and service collaboration with the Centre for Proteomic and Genomic Research (CPGR) in South Africa.

Affymetrix Introduces Axiom® MiRNA Target Site Genotyping Arrays

Affymetrix Introduces Axiom® MiRNA Target Site Genotyping Arrays

Affymetrix, Inc. (NASDAQ:AFFX) introduces Axiom® miRNA Target Site Genotyping Arrays, the only high-density genotyping tools for genome-wide evaluation of microRNA (miRNA) target sites.

Affymetrix Reports Third Quarter 2012 Results

Affymetrix Reports Third Quarter 2012 Results

Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the third quarter of 2012.

Affymetrix Introduces Axiom® Biobank Arrays For Genotyping Studies

Affymetrix Introduces Axiom® Biobank Arrays For Genotyping Studies

Affymetrix, Inc. (NASDAQ:AFFX) today introduced Axiom® Biobank Arrays, a flexible and high-powered functional biology solution for affordably genotyping large sample collections such as those screened at...

Affymetrix Reschedules The Issuance Of Third Quarter 2012 Operating Results And Conference Call To Monday November 5th, 2012 Due To Severe Weather Conditions Associated With Hurricane Sandy

Affymetrix Reschedules The Issuance Of Third Quarter 2012 Operating Results And Conference Call To Monday November 5th, 2012 Due To Severe Weather Conditions Associated With Hurricane Sandy

Affymetrix, Inc. (NASDAQ: AFFX) today announced that the company has rescheduled the issuance of third quarter 2012 operating results and the associated conference call to after market close on Monday November 5 th, ...

4 Stocks Under $10 Making Big Moves

4 Stocks Under $10 Making Big Moves

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Stocks Start Week With Stumble

Stocks Start Week With Stumble

The major U.S. equity averages finish in the red on fresh global economic worries and more weakness in the technology sector.

Affymetrix Announces Preliminary Revenue For Third Quarter 2012

Affymetrix Announces Preliminary Revenue For Third Quarter 2012

Affymetrix, Inc. (Nasdaq: AFFX) today reported that based on preliminary financial data, the Company expects total revenue of approximately $80 million for the third quarter of 2012, with revenue of approximately $18 ...

Affymetrix Launches Advanced RNA Amplification Technology For Whole-Genome Expression Analysis Of FFPE Samples

Affymetrix Launches Advanced RNA Amplification Technology For Whole-Genome Expression Analysis Of FFPE Samples

Affymetrix, Inc. (NASDAQ:AFFX) announced today the availability of SensationPlus™ FFPE Amplification and 3’ IVT Labeling Kit (SensationPlus™ FFPE Reagent Kit), consisting of RNA amplification and...

Affymetrix Inc. Stock Upgraded (AFFX)

Affymetrix Inc. Stock Upgraded (AFFX)

Affymetrix (Nasdaq:AFFX) has been upgraded by TheStreet Ratings from a sell to hold.

Affymetrix Announces Expansion Of QuantiGene® ViewRNA License For In Vitro Diagnostics And Becomes Exclusive Licensee For Chromogenic Applications

Affymetrix Announces Expansion Of QuantiGene® ViewRNA License For In Vitro Diagnostics And Becomes Exclusive Licensee For Chromogenic Applications

Affymetrix, Inc. (NASDAQ: AFFX) today announced the expansion of its license agreement with Siemens Healthcare Diagnostics for the company’s branched DNA (bDNA) technology whereby Affymetrix is the exclusive...

Affymetrix Management Discusses Q2 2012 Results - Earnings Call Transcript

Affymetrix Management Discusses Q2 2012 Results - Earnings Call Transcript

Affymetrix Management Discusses Q2 2012 Results - Earnings Call Transcript

Affymetrix Reports Second Quarter 2012 Results

Affymetrix Reports Second Quarter 2012 Results

Affymetrix, Inc., (NASDAQ:AFFX) today reported its operating results for the second quarter of 2012.

Affymetrix To Host Conference Call On July 31st, 2012 To Announce Second Quarter 2012 Operating Results

Affymetrix To Host Conference Call On July 31st, 2012 To Announce Second Quarter 2012 Operating Results

Affymetrix, Inc. (NASDAQ:AFFX) today announced that its second quarter 2012 operating results will be reported after market close on Tues.

Crossing the Five-Dollar Line

First Busey and Affymetrix shares are ready to break out as they approach a critical price.

Affymetrix Completes Acquisition Of EBioscience Holding Company, Inc.

Affymetrix Completes Acquisition Of EBioscience Holding Company, Inc.

Affymetrix Inc., (NASDAQ:AFFX) today announced that the Company has completed its acquisition of eBioscience Holding Company, Inc.

Affymetrix Announces Pricing Of Offering Of Convertible Senior Notes Due 2019

Affymetrix Announces Pricing Of Offering Of Convertible Senior Notes Due 2019

Affymetrix Inc., (Nasdaq:AFFX) announced today that it has entered into an agreement to sell $105 million aggregate principal amount of unsecured 4.

Affymetrix Stock Falls On Unusually High Volume (AFFX)

Affymetrix Stock Falls On Unusually High Volume (AFFX)

Affymetrix (Nasdaq:AFFX) is trading at unusually high volume Tuesday with 2.8 million shares changing hands. It is currently at 4.1 times its average daily volume and trading down 24 cents (-4.5%).

Affymetrix Announces Proposed $105 Million Offering Of Convertible Senior Notes Due 2019

Affymetrix Announces Proposed $105 Million Offering Of Convertible Senior Notes Due 2019

Affymetrix Inc., (NASDAQ:AFFX) today announced that it intends to offer, subject to market and other considerations, $105 million aggregate principal amount of unsecured Convertible Senior Notes due 2019.